Skip to main content

How Does Chemotherapy Work for Multiple Myeloma?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on June 4, 2025.

Official Answer by Drugs.com

Chemotherapy remains a cornerstone in managing multiple myeloma, a cancer of plasma cells in the bone marrow. While newer therapies like immunomodulators and proteasome inhibitors have expanded treatment options, chemotherapy continues to play a vital role—particularly when combined with other approaches. Here’s how it works and where it fits into modern treatment strategies.

How Chemotherapy Drugs Work Against Myeloma

Chemotherapy drugs target myeloma cells primarily by disrupting their rapid growth and division. They do this through distinct mechanisms:

It's common for doctors to use a combination of different drugs with various mechanisms of action to treat multiple myeloma. This multi-pronged approach aims to target the cancer cells from different angles, improve effectiveness, and reduce the likelihood of drug resistance. The specific combination of drugs chosen depends on factors like the patient's overall health, the characteristics of their myeloma, and whether they are eligible for a stem cell transplant.

Common Chemotherapy-Based Regimens

Modern regimens pair chemotherapy with other drug classes to improve efficacy:

Regimen Components Use Case
CyBorD Cyclophosphamide, bortezomib, dexamethasone Newly diagnosed or relapsed disease
VRd Bortezomib, lenalidomide, dexamethasone First-line induction therapy
VTD Bortezomib, thalidomide, dexamethasone Transplant-eligible patients
Doxil + Bortezomib Liposomal doxorubicin with proteasome inhibitor Relapsed/refractory cases

These combinations leverage chemotherapy’s cell-killing power alongside drugs that enhance immune targeting or disrupt protein recycling in cancer cells. They are often first-line induction therapies for transplant-eligible patients.

When Is Chemotherapy Used in Myeloma?

While chemotherapy was once a primary treatment for multiple myeloma, its role has evolved with the advent of more targeted therapies. Today, it's generally used in specific situations, often in combination with other drugs.

Here are some scenarios where chemotherapy is still used in myeloma treatment:

Before a Stem Cell Transplant (Induction Therapy): This is one of the most common uses. High-dose chemotherapy, particularly with drugs like melphalan, is used to "condition" the patient before an autologous stem cell transplant. The goal is to aggressively reduce the number of myeloma cells in the bone marrow, creating space for the transplanted healthy stem cells to engraft and rebuild the blood-forming system.

As part of Initial (First-Line) Treatment for Newly Diagnosed Myeloma:

For Relapsed or Refractory Myeloma: If myeloma returns after initial treatment (relapsed) or stops responding to ongoing treatment (refractory), chemotherapy might be reintroduced, often in new combinations with other agents, to try and regain control of the disease.

To Manage Symptoms (Palliative Care): In advanced cases, chemotherapy might be used to help reduce pain and manage other symptoms associated with the cancer, aiming to improve the patient's quality of life.

Related questions

Side Effects and Management

As chemotherapy targets rapidly dividing cells, it can affect healthy cells and lead to a wide range of side effects. These are carefully managed by the healthcare team.

Common effects of chemotherapy for multiple myeloma include:

Some side effects can be prevented or managed with supportive care, such as anti-nausea medications (e.g., ondansetron), growth factors (e.g., filgrastim), and infection prevention.

Long-term alkylating agent use raises risks of secondary cancers and lung scarring, necessitating careful monitoring.

Summary

While not a standalone cure, chemotherapy’s synergy with targeted therapies and transplants makes it an important part of myeloma treatment. From induction to relapse, its DNA-damaging action remains a key tool for controlling disease progression and improving survival. Advances like liposomal formulations and enzyme-activated prodrugs continue refining its role, balancing efficacy with patient safety.

References
  1. American Cancer Society. 2025. Drug Therapy for Multiple Myeloma. Accessed on June 4, 2025 at https://www.cancer.org/cancer/types/multiple-myeloma/treating/chemotherapy.html
  2. Cancer Research UK. 2024. First treatment for myeloma. Accessed on June 4, 2025 at https://www.cancerresearchuk.org/about-cancer/myeloma/treatment/first-treatment-for-myeloma
  3. International Myeloma Foundation. Frontline Myeloma Treatment Options. Accessed on June 4, 2025 at https://www.myeloma.org/frontline-treatment-options
  4. International Myeloma Foundation. Melphalan (Alkeran). Accessed on June 4, 2025 at https://www.myeloma.org/treatment/multiple-myeloma-medications/melphalan-alkeran
  5. Leukemia & Lymphoma Society. Chemotherapy and Drug Therapy. Accessed on June 4, 2025 at https://www.lls.org/myeloma/treatment/chemotherapy-and-drug-therapy
  6. Leukemia & Lymphoma Society. Side Effects of Myeloma Treatment. Accessed on June 4, 2025 at https://www.lls.org/myeloma/treatment/side-effects
  7. Reeder, C. B., et. al. 2009. Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial. Leukemia, 23(7), 1337–1341. https://doi.org/10.1038/leu.2009.26

Read next

Radiation vs. Chemo: Which cancer treatment is right for you?

Chemotherapy treats cancer throughout the body, while radiation targets specific areas. Each approach has unique benefits depending on the type and stage of cancer, as well as your overall health.

Continue reading

How long does chemo take? Sessions, cycles, and recovery time?

The duration of chemotherapy varies significantly based on cancer type, treatment goals, and individual patient health. Some patients may complete treatment in a few months, while others require therapy for a year or longer.

Continue reading

How soon will my hair grow back after chemotherapy?

After finishing chemotherapy, some may notice fine, soft hair appearing as early as 3 to 6 weeks after treatment ends. It can take several months for your hair to return to its previous length and thickness, and there may be temporary changes in texture or color.

Continue reading

See also:

Related medical questions

Drug information

Related support groups